News

Filter

1 to 9 of 51 results

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

Sanofi Pasteur gains FDA approval of Fluzone Intradermal Quadrivalent for adults

13-12-2014

French pharma major Sanofi’s vaccines division, Sanofi Pasteur, has received approval from the US Food…

Anti-viralsFluzonePharmaceuticalRegulationSanofiSanofi PasteurUSAVaccines

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

Sanofi reports positive data in Phase III dengue vaccine trial, with 95.5% efficacy against severe dengue

04-11-2014

French drug major Sanofi has reported positive data with its experimental tetravalent dengue vaccine…

Anti-viralsFrancePharmaceuticalResearchSanofi Pasteur

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

Sanofi Pasteur and Immune Design announce herpes vaccine collaboration

16-10-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, and Immune Design, a clinical-stage…

FranceImmune DesignPharmaceuticalResearchSanofi PasteurVaccines

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

Sanofi Pasteur achieves primary endpoint in Dengue fever vaccine in Latin America trial

03-09-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has achieved its primary endpoint…

Anti-viralsDengueDengue feverPharmaceuticalSanofi PasteurSouth AmericaTropical diseases

Sanofi Pasteur announces positive results for Fluzone’s higher dose

Sanofi Pasteur announces positive results for Fluzone’s higher dose

14-08-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has found that Fluzone High-Dose was…

Anti-viralsFluzonePharmaceuticalResearchSanofiSanofi PasteurUSAVaccinationVaccines

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

11-07-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has announced detailed results of…

FrancePharmaceuticalResearchSanofi PasteurVaccines

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

Japan marketing approval for Canaglu; vaccine license for Daiichi Sankyo

04-07-2014

Japanese drug major Mitsubishi Tanabe Pharma has received approval to manufacture and market the SGLT2…

canagliflozinCanagluDaiichi SankyoDiabetesJapanMitsubishi TanabePharmaceuticalRegulationSanofi PasteurVaccines

CureVac in deal with Sanofi Pasteur for mRNA-based prophylactic vaccine

01-07-2014

German clinical-stage biopharma company CureVac has entered into an exclusive license agreement with…

LicensingPharmaceuticalSanofiSanofi PasteurVaccines

1 to 9 of 51 results

COMPANY SPOTLIGHT

Menarini

Back to top